- Home
- CLDX vs SDGR Comparison
CLDX vs SDGR Comparison
Compare CLDX & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- SDGR
- Stock Information
- Founded
- CLDX 1983
- SDGR 1990
- Country
- CLDX United States
- SDGR United States
- Employees
- CLDX N/A
- SDGR N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- CLDX Health Care
- SDGR Health Care
- Exchange
- CLDX Nasdaq
- SDGR Nasdaq
- Market Cap
- CLDX 1.8B
- SDGR 1.6B
- IPO Year
- CLDX 2008
- SDGR 2020
- Fundamental
- Price
- CLDX $25.14
- SDGR $19.08
- Analyst Decision
- CLDX Buy
- SDGR Buy
- Analyst Count
- CLDX 7
- SDGR 10
- Target Price
- CLDX $64.83
- SDGR $32.90
- AVG Volume (30 Days)
- CLDX 914.2K
- SDGR 557.0K
- Earning Date
- CLDX 02-24-2025
- SDGR 11-12-2024
- Dividend Yield
- CLDX N/A
- SDGR N/A
- EPS Growth
- CLDX N/A
- SDGR N/A
- EPS
- CLDX N/A
- SDGR N/A
- Revenue
- CLDX $9,976,000.00
- SDGR $193,348,000.00
- Revenue This Year
- CLDX N/A
- SDGR N/A
- Revenue Next Year
- CLDX N/A
- SDGR $26.50
- P/E Ratio
- CLDX N/A
- SDGR N/A
- Revenue Growth
- CLDX 128.55
- SDGR N/A
- 52 Week Low
- CLDX $22.93
- SDGR $16.67
- 52 Week High
- CLDX $53.18
- SDGR $37.48
- Technical
- Relative Strength Index (RSI)
- CLDX 47.58
- SDGR 47.77
- Support Level
- CLDX $24.14
- SDGR $19.40
- Resistance Level
- CLDX $25.83
- SDGR $20.48
- Average True Range (ATR)
- CLDX 1.23
- SDGR 1.08
- MACD
- CLDX 0.02
- SDGR -0.22
- Stochastic Oscillator
- CLDX 48.41
- SDGR 37.41
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.